HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter.

AbstractBACKGROUND:
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in malignant cells but not in normal cells. Ad/g-TRAIL, an adenoviral vector in which expression of green fluorescent protein (GFP) and TRAIL is driven by a human telomerase reverse transcriptase promoter, has shown promise as a targeted antitumor agent.
METHODS:
To investigate the effects of TRAIL gene therapy on pancreatic cancer, BxPC-3, MIA-PaCa-2, Panc-1, and ASPC-1 cells were treated with Ad/g-TRAIL. Transfection and protein expression were determined by using immunoblotting and identification of GFP with fluorescent microscopy and flow cytometry. Cell viability was determined by proliferation assay. Cell-cycle analysis and quantification of caspase-3 were used to identify apoptosis. The in vivo efficacy of Ad/g-TRAIL was characterized in a novel red fluorescent protein murine model of MIA-PaCa-2 pancreatic cancer.
RESULTS:
Cells treated with Ad/g-TRAIL expressed GFP and exhibited apoptotic morphology within 2 days of treatment. Treatment with this vector in vitro resulted in less cell viability, increased caspase-3 activity, and a greater apoptotic fraction than treatment with controls. In vivo, treatment with Ad/g-TRAIL significantly suppressed tumor growth.
CONCLUSIONS:
TRAIL gene therapy induces apoptosis of pancreatic tumor cells both in vitro and in vivo and is a promising therapy in the treatment of pancreatic cancer.
AuthorsMatthew H Katz, Daniel E Spivack, Shinako Takimoto, Bingliang Fang, Douglas W Burton, A R Moossa, Robert M Hoffman, Michael Bouvet
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 10 Issue 7 Pg. 762-72 (Aug 2003) ISSN: 1068-9265 [Print] United States
PMID12900367 (Publication Type: Journal Article)
Chemical References
  • Apoptosis Regulatory Proteins
  • DNA-Binding Proteins
  • Luminescent Proteins
  • Membrane Glycoproteins
  • TNF-Related Apoptosis-Inducing Ligand
  • TNFSF10 protein, human
  • Tnfsf10 protein, mouse
  • Tumor Necrosis Factor-alpha
  • red fluorescent protein
  • Green Fluorescent Proteins
  • Telomerase
  • CASP3 protein, human
  • Casp3 protein, mouse
  • Caspase 3
  • Caspases
Topics
  • Adenoviridae
  • Animals
  • Apoptosis Regulatory Proteins
  • Blotting, Western
  • Carcinoma, Pancreatic Ductal (therapy)
  • Caspase 3
  • Caspases (metabolism)
  • Catalytic Domain
  • DNA-Binding Proteins
  • Genes, Transgenic, Suicide
  • Genetic Therapy
  • Green Fluorescent Proteins
  • Humans
  • Insect Vectors
  • Luminescent Proteins (metabolism, therapeutic use)
  • Membrane Glycoproteins (therapeutic use)
  • Mice
  • Pancreatic Neoplasms (therapy)
  • TNF-Related Apoptosis-Inducing Ligand
  • Telomerase (therapeutic use)
  • Transfection
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: